Research and Markets: This Essential Disease and Therapy Review on Hepatitis C Provides a Comprehensive Overview of the Disease, Diagnosis and Treatment

* Reuters is not responsible for the content in this press release.

Wed Oct 14, 2009 7:10am EDT

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/ccdabb/disease_and_therap) has
announced the addition of the "Disease and Therapy Review: Hepatitis C" report
to their offering. 

The Hepatitis C Disease and Therapy Review provides an overview of the disease
and related conditions, with incidence and prevalence numbers and percentages
for major countries worldwide, information on diagnosis, and an overview of
treatment. Dosing and treatment cost information is provided for various
treatment types. General information on the market for drugs treating hepatitis
C patients, as well as sales of leading drugs and therapies are provided. 

Disease and Therapy Reviews were developed to provide a basic understanding of
the key facts about a disease and market in a quick, easy-to-read format. These
reports are prepared by the senior market research team of Timely Data
Resources. Each Disease and Therapy Review provides a concise analysis of the
most important information about a particular disease, its treatment, and the
market opportunities. Reports begin with an overview of the condition, and also
contain tables that summarize the available worldwide incidence and prevalence
data for the condition, a review of current diagnosis strategies and treatment
options, general information about the market size, and information about
important market trends. The data contained in these reports comes from key
industry secondary data sources, such as the Timely Data Resources Incidence and
Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This
information is supplemented by reviews of analyst reports, company reports, and
medical websites. Sources and references are provided. 

Key Topics Covered:

* OVERVIEW 
* INCIDENCE AND PREVALENCE 
* TREATMENT 
* DOSING 
* TREATMENT COSTS 
* MARKET SIZE 
* COMMENTS 
* REFERENCES/RESOURCES

For more information visit
http://www.researchandmarkets.com/research/ccdabb/disease_and_therap

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.